Immage Biotherapeutics Corp logo

Immage Biotherapeutics Corp

IMMG · OTC · Finance, Financial Conglomerates · Founded 2012

Immage Biotherapeutics Corp. is a biotechnology company, which develops novel immunotherapy biologics to treat various cancers. The firm develops, markets, and licenses its patented immunotherapy candidate for MAGE A. It encompasses vaccines, oncolytic viruses, adjuvants, and adoptive t-cell technologies.

Current Price
$0.00
Market Cap
$0K
Return Since Last Split
-100%
Last Split
Feb 13, 2015
Total Splits
1
Cumulative Multiple
273×

What If You Bought IMMG Earlier?

Investment
Purchase Date (Before Split)
Worth Today
$0
27,300 shares · 273×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Feb 13, 2015—273-for-1273×273×

Immage Biotherapeutics Corp Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

Immage Biotherapeutics Corp's latest record in the split calendar is a 273-for-1 forward split effective 2015-02-13.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.